BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1791980)

  • 1. Cysteinyldopamine is not incorporated into neuromelanin.
    Wakamatsu K; Ito S; Nagatsu T
    Neurosci Lett; 1991 Sep; 131(1):57-60. PubMed ID: 1791980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuromelanin of the human substantia nigra.
    Carstam R; Brinck C; Hindemith-Augustsson A; Rorsman H; Rosengren E
    Biochim Biophys Acta; 1991 Sep; 1097(2):152-60. PubMed ID: 1911888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structure of neuromelanin as studied by chemical degradative methods.
    Wakamatsu K; Fujikawa K; Zucca FA; Zecca L; Ito S
    J Neurochem; 2003 Aug; 86(4):1015-23. PubMed ID: 12887698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromelanin of the human substantia nigra: a mixed-type melanin.
    Odh G; Carstam R; Paulson J; Wittbjer A; Rosengren E; Rorsman H
    J Neurochem; 1994 May; 62(5):2030-6. PubMed ID: 8158151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins.
    Double KL; Zecca L; Costi P; Mauer M; Griesinger C; Ito S; Ben-Shachar D; Bringmann G; Fariello RG; Riederer P; Gerlach M
    J Neurochem; 2000 Dec; 75(6):2583-9. PubMed ID: 11080212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural investigations of neuromelanin by pyrolysis-gas chromatography/mass spectrometry.
    Dzierzega-Lecznar A; Kurkiewicz S; Stepien K; Chodurek E; Riederer P; Gerlach M
    J Neural Transm (Vienna); 2006 Jun; 113(6):729-34. PubMed ID: 16755376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromelanin of the human substantia nigra: an update.
    Zucca FA; Basso E; Cupaioli FA; Ferrari E; Sulzer D; Casella L; Zecca L
    Neurotox Res; 2014 Jan; 25(1):13-23. PubMed ID: 24155156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthetic pathway to neuromelanin and its aging process.
    Wakamatsu K; Murase T; Zucca FA; Zecca L; Ito S
    Pigment Cell Melanoma Res; 2012 Nov; 25(6):792-803. PubMed ID: 22938712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of L-cysteine on the oxidation chemistry of dopamine: new reaction pathways of potential relevance to idiopathic Parkinson's disease.
    Zhang F; Dryhurst G
    J Med Chem; 1994 Apr; 37(8):1084-98. PubMed ID: 7909337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GC/MS analysis of thermally degraded neuromelanin from the human substantia nigra.
    Dzierzega-Lecznar A; Kurkiewicz S; Stepien K; Chodurek E; Wilczok T; Arzberger T; Riederer P; Gerlach M
    J Am Soc Mass Spectrom; 2004 Jun; 15(6):920-6. PubMed ID: 15144983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of neuromelanin and iron in substantia nigra and other areas of human brain.
    Zecca L; Shima T; Stroppolo A; Goj C; Battiston GA; Gerbasi R; Sarna T; Swartz HM
    Neuroscience; 1996 Jul; 73(2):407-15. PubMed ID: 8783258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of human substantia nigra neuromelanin with lipids and peptides.
    Zecca L; Costi P; Mecacci C; Ito S; Terreni M; Sonnino S
    J Neurochem; 2000 Apr; 74(4):1758-65. PubMed ID: 10737635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purified human neuromelanin, synthetic dopamine melanin as a potential model pigment, and the normal human substantia nigra: characterization by electron paramagnetic resonance spectroscopy.
    Enochs WS; Nilges MJ; Swartz HM
    J Neurochem; 1993 Jul; 61(1):68-79. PubMed ID: 8390568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: an electron paramagnetic resonance spectroscopy study.
    Shima T; Sarna T; Swartz HM; Stroppolo A; Gerbasi R; Zecca L
    Free Radic Biol Med; 1997; 23(1):110-9. PubMed ID: 9165303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mössbauer spectroscopic studies of purified human neuromelanin isolated from the substantia nigra.
    Gerlach M; Trautwein AX; Zecca L; Youdim MB; Riederer P
    J Neurochem; 1995 Aug; 65(2):923-6. PubMed ID: 7616255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical degradation of melanins: application to identification of dopamine-melanin.
    Ito S; Wakamatsu K
    Pigment Cell Res; 1998 Apr; 11(2):120-6. PubMed ID: 9585251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The enigma of neuromelanin in Parkinson's disease substantia nigra.
    Youdim MB; Ben-Shachar D; Riederer P
    J Neural Transm Suppl; 1994; 43():113-22. PubMed ID: 7884393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics.
    Zecca L; Zucca FA; Wilms H; Sulzer D
    Trends Neurosci; 2003 Nov; 26(11):578-80. PubMed ID: 14585596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total and paramagnetic metals in human substantia nigra and its neuromelanin.
    Zecca L; Swartz HM
    J Neural Transm Park Dis Dement Sect; 1993; 5(3):203-13. PubMed ID: 8396395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does tyrosinase exist in neuromelanin-pigmented neurons in the human substantia nigra?
    Ikemoto K; Nagatsu I; Ito S; King RA; Nishimura A; Nagatsu T
    Neurosci Lett; 1998 Sep; 253(3):198-200. PubMed ID: 9792245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.